Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Narrative review to capture patients’ perceptions and opinions about non-response and response to biological therapy for severe asthma
Courtney Coleman, Ekaterina Khaleva, Anna Rattu, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 1, pp. 2200837-2200837
Open Access | Times Cited: 16

Showing 16 citing articles:

Definitions of non-response and response to biological therapy for severe asthma: a systematic review
Ekaterina Khaleva, Anna Rattu, Christopher E. Brightling, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00444-2022
Open Access | Times Cited: 18
Treatable traits models of care
Vanessa M. McDonald, Anne E. Holland
Respirology (2023) Vol. 29, Iss. 1, pp. 24-35
Open Access | Times Cited: 15
What bothers severe asthma patients most? A paired patient–clinician study across seven European countries
Ben Ainsworth, Eleanor Chatburn, Aruna T. Bansal, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00717-2022
Open Access | Times Cited: 10
Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
Yoni E. van Dijk, Niels W. Rutjes, Korneliusz Golebski, et al.
Pediatric Drugs (2023) Vol. 25, Iss. 6, pp. 677-693
Open Access | Times Cited: 10
Emerging biological treatments for asthma
Daniela Pastore, Chiara Lupia, Maria D’Amato, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
Severe Asthma Questionnaire (SAQ) and Asthma Control Questionnaire (ACQ) as Early Predictors of Biologic Response in Severe Asthma
Drew Davies, Joseph W. Lanario, Michael E. Hyland, et al.
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 743-752
Open Access
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?
Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, et al.
Pragmatic and Observational Research (2024) Vol. Volume 15, pp. 45-51
Open Access | Times Cited: 3
Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission
Andriana Ι. Papaioannou, Evangelia Fouka, Κonstantinos Bartziokas, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 6, pp. 481-493
Closed Access | Times Cited: 8
“Life-changing”: the experience of super-responders to biologics in severe asthma
Joseph W. Lanario, Lucy Cartwright, Rupert Jones, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
Luis Pérez de Llano, Ghislaine Scélo, Giorgio Walter Canonica, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 5, pp. 610-622.e7
Open Access | Times Cited: 5
The Role of Macrophage Autophagy in Asthma: A Novel Therapeutic Strategy
Lijie Wang, Xingxing Yuan, Zhuying Li, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 5
Patient-reported outcomes: missing in asthma remission
Amy Hai Yan Chan, Paul Leong, John D. Politis, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 9, pp. 665-666
Closed Access | Times Cited: 1
Clinical Trial Design Innovations for Precision Medicine in Asthma
Salman Siddiqui, Elin Haf Davies, Majid Afshar, et al.
Advances in experimental medicine and biology (2023), pp. 395-412
Closed Access | Times Cited: 3
Immunobiological therapy in the treatment of severe asthma
David Evangelista Barros de Oliveira, Carlos Gustavo Alves Leitão, F Falcão, et al.
Research Society and Development (2024) Vol. 13, Iss. 5, pp. e14513545933-e14513545933
Open Access
From Innovator Result-driven to Multi-actor Impact-oriented Public–Private Partnerships: Integrating the Patient Perspective
Remco L.A. de Vrueh, Jon S. B. de Vlieger, Kristina M. Orrling, et al.
Handbook of experimental pharmacology (2024)
Closed Access
Defining the questions to be asked in severe asthma trials: data from the COMSA working group
Thomas Eiwegger, Sarah Bendien
European Respiratory Journal (2023) Vol. 61, Iss. 4, pp. 2202058-2202058
Closed Access
Page 1

Scroll to top